Short Interest in Haleon plc (NYSE:HLN) Rises By 6.8%

Haleon plc (NYSE:HLN) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 18,140,000 shares, a growth of 6.8% from the December 15th total of 16,990,000 shares. Approximately 0.4% of the shares of the stock are short sold. Based on an average trading volume of 6,580,000 shares, the short-interest ratio is presently 2.8 days.

Haleon Trading Up 0.5 %

NYSE HLN opened at $9.24 on Tuesday. The stock has a 50-day moving average of $9.54 and a 200-day moving average of $9.72. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon has a 1-year low of $7.89 and a 1-year high of $10.80. The firm has a market cap of $41.80 billion, a PE ratio of 27.16, a price-to-earnings-growth ratio of 2.52 and a beta of 0.29.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. AE Wealth Management LLC increased its stake in shares of Haleon by 6.1% during the second quarter. AE Wealth Management LLC now owns 19,199 shares of the company’s stock valued at $159,000 after buying an additional 1,098 shares during the period. Lake Street Advisors Group LLC lifted its position in shares of Haleon by 5.4% in the 3rd quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company’s stock worth $237,000 after purchasing an additional 1,143 shares during the period. Synovus Financial Corp boosted its stake in shares of Haleon by 0.8% during the 3rd quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock valued at $1,575,000 after purchasing an additional 1,216 shares in the last quarter. Hexagon Capital Partners LLC increased its position in shares of Haleon by 18.5% during the third quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company’s stock valued at $84,000 after buying an additional 1,238 shares during the period. Finally, Peapack Gladstone Financial Corp lifted its holdings in Haleon by 3.2% in the third quarter. Peapack Gladstone Financial Corp now owns 44,844 shares of the company’s stock worth $474,000 after buying an additional 1,390 shares during the period. Institutional investors own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. UBS Group upgraded Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Finally, Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $10.95.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.